EYE XCEL LIMITED

Company number 05814814 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Industry Analysis: Eye Xcel Limited

1. Industry Classification

Sector: Healthcare Services – Optometry (SIC 86900: Other Human Health Activities)

Sub-sector Context: Independent optometry practice operating under the Boots Opticians franchise model, generating revenue through NHS-funded sight tests, private examinations, and retail dispensing of spectacles and contact lenses.

Key Industry Characteristics: - The UK optometry market is valued at approximately £2.8 billion, dominated by vertically-integrated chains (Specsavers holds ~40% market share, followed by Vision Express, Boots Opticians, and Scrivens) - Capital-intensive entry requirements: ophthalmic equipment, diagnostic technology, and regulatory-compliant premises - Dual revenue model: NHS sight test funding (approximately £22.50 per test) plus private dispensing income - Regulatory oversight by the General Optical Council (GOC) and compliance with the Opticians Act - Growing pressure from online retailers (e.g., Glasses Direct) and corporate acquisitions consolidating independent practices


2. Relative Performance

Balance Sheet Health – Concerning Trajectory

Metric 2025 2024 2023 2022 2017
Net Assets (£35,867) (£48,128) £6,072 £42,300 £187,603
Net Current Assets/Liabilities (£271,512) (£226,413) N/A N/A N/A
Cash £38,579 £18,721 £14,199 £84,198 £51,350
Total Assets £791,350 £792,834 £790,508 £879,088 £815,129

Assessment: The company is technically insolvent, with a shareholders' deficit of £35,867 as at September 2025. While this represents a modest improvement from the prior year's deficit of £48,128, the trajectory over the past eight years is deeply concerning—equity has eroded from £187,603 in 2017 to negative territory. This significantly underperforms typical optometry practices, which generally maintain positive net assets of £50,000–£200,000 for practices of comparable scale.

Working Capital Position: Net current liabilities of £271,512 (worsening from £226,413 in 2024) indicate severe liquidity strain. The practice is reliant on creditor support and long-term debt structures to fund operations—this is atypical for the sector, where practices normally maintain positive working capital cycles due to the mix of NHS payments and retail cash receipts.

Cash Improvement: The cash position has improved from £18,721 to £38,579, suggesting some operational cash generation. However, this must be contextualised against the declining asset base and increasing current liabilities—cash has been generated at the expense of balance sheet strength.

Asset Composition

The balance sheet is heavily weighted toward fixed assets (£672,955 or 85% of total assets), comprising: - Goodwill: £62,660 (amortising from £67,882)—indicates the practice was acquired rather than established organically - Tangible assets: £610,295 (declining from £622,594)—likely includes practice equipment, fixtures, fittings, and potentially the property interest at 35 Queensway, Stevenage

This asset profile is consistent with the optometry sector's capital-intensive nature, but the concentration in fixed assets with minimal working capital creates vulnerability to revenue disruption.


3. Sector Trends Impact

Positive Tailwinds

  • Ageing population: The UK's demographic shift supports long-term demand growth for optometric services, with over-60s requiring more frequent examinations
  • NHS contract stability: While not generous, NHS sight test funding provides a predictable revenue baseline
  • Myopia epidemic: Increasing screen time and lifestyle changes are driving demand, particularly among younger demographics

Negative Headwinds

  • Online disruption: Direct-to-consumer eyewear retailers continue to erode dispensing margins, which represent the primary profit centre for practices
  • Corporate consolidation: Specsavers' vertically-integrated model and aggressive expansion, combined with private equity acquisitions of independent chains, squeeze smaller operators
  • NHS funding pressure: Real-terms decline in NHS sight test fees and optical voucher values compresses margins
  • Rising operational costs: Energy, staffing (particularly qualified dispensing opticians), and business rates in retail locations have escalated significantly since 2020
  • Technology investment requirements: Digital imaging, OCT scanners, and electronic patient records demand ongoing capital expenditure

Franchise Model Considerations

Operating under the Boots Opticians franchise provides brand recognition and supply chain advantages, but typically involves: - Franchise fees and profit-sharing arrangements reducing margins - Restricted purchasing autonomy - Compliance requirements that may limit operational flexibility

The long-term creditor position (£432,143 falling due after more than one year, reduced from £507,024) likely includes franchise-related financing or related party loans—this debt structure is characteristic of franchise acquisitions in the sector.


4. Competitive Positioning

Market Position: Niche Player (Under Pressure)

Eye Xcel operates as a single-site franchisee within the Boots Opticians network in Stevenage, Hertfordshire. This positions the company as:

  • Local presence in a market town with moderate competition from other multiples and independents
  • Brand affiliation with a recognised high-street retailer
  • Scale disadvantage versus both corporate chains and larger independent groups with multiple practices

Strengths

  1. Boots Opticians brand: Consumer trust and footfall from the broader Boots retail ecosystem
  2. Cash generation: The improvement in cash from £18,721 to £38,579 suggests underlying operational viability
  3. Debt reduction: Long-term creditors reduced by £74,881, indicating active deleveraging
  4. Established presence: Trading since 2006, providing local market knowledge and patient loyalty

Weaknesses

  1. Technical insolvency: Negative shareholders' equity severely limits financial flexibility and borrowing capacity
  2. Deteriorating working capital: Net current liabilities of £271,512 create ongoing solvency risk
  3. Asset erosion: Total assets have declined from £1.06M (2020) to £791,350 (2025), a 25.5% reduction suggesting either asset disposals, insufficient reinvestment, or both
  4. Single-site concentration: No geographic diversification; wholly dependent on the Stevenage location's performance
  5. Minimal cash reserves: £38,579 provides limited buffer against disruption or equipment failure
  6. Director dependency: Single director (Mrs Dipta Khagram) creates key-person risk

Competitive Comparison

Typical financial metrics for independent optometry practices: - Net profit margins: 15-25% of revenue for well-managed practices - Current ratio: 1.5-2.5x (Eye Xcel: significantly below 1.0x) - Return on assets: 8-15% (Eye Xcel: negative equity returns) - Debt-to-equity: 0.5-1.5x for leveraged acquisitions (Eye Xcel: incalculable due to negative equity)

Eye Xcel substantially underperforms sector norms on every financial metric. The practice appears to be struggling with the legacy debt from its acquisition (evidenced by goodwill), compounded by declining asset values and working capital deterioration.


Viability Assessment

The going concern basis appears to depend upon: 1. Continued creditor forbearance: The practice requires ongoing support from long-term creditors (likely including related party or franchise financing) 2. Operational cash generation: Recent cash improvement is encouraging but must be sustained and accelerated 3. Absence of significant capital expenditure requirements: Any major equipment replacement or regulatory compliance investment could prove terminal given the balance sheet position

The reduction in long-term creditors by £74,881 and improvement in the equity deficit by £12,261 suggest the business is generating modest positive operational performance, but the pace of recovery is insufficient to restore balance sheet health within a reasonable timeframe without significant revenue growth or restructuring.

Perspective: Industry Sector Analyst · Model: glm-5.1 · Generated 11 August 2026